{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T04:58:37Z","timestamp":1793336317723,"version":"4.5.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.cgh.2018.05.011","type":"journal-article","created":{"date-parts":[[2018,7,11]],"date-time":"2018-07-11T09:20:25Z","timestamp":1531300825000},"page":"192-199.e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["An Imaging Biomarker for Assessing Hepatic Function in Patients With Primary Sclerosing Cholangitis"],"prefix":"10.1016","volume":"17","author":[{"given":"Jennifer","family":"Schulze","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrike","family":"Lenzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan B.","family":"Hinrichs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burckhardt","family":"Ringe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Manns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Wacker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina I.","family":"Ringe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1016\/j.cgh.2018.05.011_bib1","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1016\/j.jhep.2008.01.020","article-title":"The challenges in primary sclerosing cholangitis\u2013aetiopathogenesis, autoimmunity, management and malignancy","volume":"48","author":"Weismuller","year":"2008","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2018.05.011_bib2","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1002\/ibd.21219","article-title":"Hepatopancreatobiliary manifestations and complications associated with inflammatory bowel disease","volume":"16","author":"Navaneethan","year":"2010","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2018.05.011_bib3","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/lt.24350","article-title":"Biliary strictures and recurrence after liver transplantation for primary sclerosing cholangitis: A retrospective multicenter analysis","volume":"22","author":"Hildebrand","year":"2016","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cgh.2018.05.011_bib4","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1136\/gut.51.4.562","article-title":"Natural history of primary sclerosing cholangitis and prognostic value of cholangiography in a Dutch population","volume":"5","author":"Ponsioen","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2018.05.011_bib5","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/hep.26620","article-title":"Radiologic course of primary sclerosing cholangitis: assessment by three-dimensional magnetic resonance cholangiography and predictive features of progression","volume":"59","author":"Ruiz","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2018.05.011_bib6","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1053\/j.gastro.2017.02.038","article-title":"Patient age, sex, and inflammatory bowel disease phenotype associate with course of primary sclerosing cholangitis","volume":"152","author":"Weismuller","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2018.05.011_bib7","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/S0025-6196(11)64614-4","article-title":"A\u00a0revised natural history model for primary sclerosing cholangitis","volume":"75","author":"Kim","year":"2000","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.cgh.2018.05.011_bib8","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/hep.23294","article-title":"Diagnosis and management of primary sclerosing cholangitis","volume":"51","author":"Chapman","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2018.05.011_bib9","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/MOG.0000000000000163","article-title":"Biomarkers for disease progression of primary sclerosing cholangitis","volume":"31","author":"de Vries","year":"2015","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.cgh.2018.05.011_bib10","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1002\/hep.29293","article-title":"Recommendations on the use of magnetic resonance imaging in PSC: a position statement from the International PSC Study Group","volume":"66","author":"Schramm","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2018.05.011_bib11","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1002\/hep.28256","article-title":"Surrogate endpoints for clinical trials in primary sclerosing cholangitis: Review and results from an International PSC Study Group consensus process","volume":"63","author":"Ponsioen","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2018.05.011_bib12","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1002\/jhbp.238","article-title":"Short-term prognostic factors for primary sclerosing cholangitis","volume":"22","author":"Watanabe","year":"2015","journal-title":"J\u00a0Hepatobiliary Pancreat Sci"},{"key":"10.1016\/j.cgh.2018.05.011_bib13","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jhep.2009.04.009","article-title":"EASL Clinical Practice Guidelines: management of cholestatic liver diseases","volume":"51","author":"European Association for the Study of the Liver","year":"2009","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2018.05.011_bib14","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1007\/s00330-015-3913-y","article-title":"Functional gadoxetate disodium-enhanced MRI in patients with primary sclerosing cholangitis (PSC)","volume":"26","author":"Hinrichs","year":"2016","journal-title":"Eur Radiol"},{"key":"10.1016\/j.cgh.2018.05.011_bib15","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1002\/jmri.24250","article-title":"Dynamic gadoxetate-enhanced MRI for the assessment of total and segmental liver function and volume in primary sclerosing cholangitis","volume":"39","author":"Nilsson","year":"2014","journal-title":"J\u00a0Magn Reson Imaging"},{"key":"10.1016\/j.cgh.2018.05.011_bib16","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/jmri.24381","article-title":"Gadoxetate disodium in patients with primary sclerosing cholangitis: an analysis of hepatobiliary contrast excretion","volume":"40","author":"Ringe","year":"2014","journal-title":"J\u00a0Magn Reson Imaging"},{"key":"10.1016\/j.cgh.2018.05.011_bib17","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0022-3565(24)34879-7","article-title":"Hepatic uptake of the magnetic resonance imaging contrast agent gadoxetate disodium by the organic anion trnasporting polypeptide Oatp1","volume":"290","author":"van Motfoort","year":"1999","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.cgh.2018.05.011_bib18","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1053\/jhep.2001.22172","article-title":"A\u00a0model to predict survival in patients with end-stage liver disease","volume":"33","author":"Kamath","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2018.05.011_bib19","article-title":"A\u00a0novel prognostic model for transplant-free survival in primary sclerosing cholangitis","author":"de Vries","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2018.05.011_bib20","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1055\/s-0030-1255527","article-title":"Validation of a cholangiographic prognostic model in primary sclerosing cholangitis","volume":"42","author":"Ponsioen","year":"2010","journal-title":"Endoscopy"},{"key":"10.1016\/j.cgh.2018.05.011_bib21","first-page":"333","article-title":"The Brisbane 2000 terminology of liver anatomy and resections","volume":"2","author":"Belghiti","year":"2000","journal-title":"HBP"},{"key":"10.1016\/j.cgh.2018.05.011_bib22","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.ejrad.2013.12.010","article-title":"Gd-EOB-DTPA enhanced MRI of the liver: correlation of relative hepatic enhancement, relative renal enhancement, and liver to kidneys enhancement ratio with serum hepatic enzyme levels and eGFR","volume":"83","author":"Talakic","year":"2014","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.cgh.2018.05.011_bib23","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1007\/s00330-014-3108-y","article-title":"Assessing liver function by liver enhancement during the hepatobiliary phase with Gd-EOB-DTPA-enhanced MRI at 3 Tesla","volume":"24","author":"Verloh","year":"2014","journal-title":"Eur Radiol"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S154235651830497X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S154235651830497X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:29:33Z","timestamp":1761542973000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S154235651830497X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S154235651830497X"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2018.05.011","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An Imaging Biomarker for Assessing Hepatic Function in Patients With Primary Sclerosing Cholangitis","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2018.05.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 by the AGA Institute","name":"copyright","label":"Copyright"}]}}